Journal of Pharmaceutical Sciences

Cover image for Vol. 102 Issue 6

June 2013

Volume 102, Issue 6

Pages i–ii, 1689–2067

  1. Issue Information

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. Issue Information (pages i–ii)

      Version of Record online: 16 MAY 2013 | DOI: 10.1002/jps.23598

  2. Editorial

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. Editorial

      Editorial (page 1689)

      Ronald T. Borchardt

      Version of Record online: 8 APR 2013 | DOI: 10.1002/jps.23527

  3. Rapid Communication

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. Fill volume as an indicator of surface heterogeneity in glass vials for parenteral packaging (pages 1690–1695)

      Nathan W. Kucko, Tim Keenan, Aisling Coughlan and Matthew M. Hall

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23520

  4. Rapid Communications

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. Differentiation of subvisible silicone oil droplets from irregular standard dust particles (pages 1696–1700)

      Nathan Vandesteeg and Cathy Kilbert

      Version of Record online: 17 APR 2013 | DOI: 10.1002/jps.23554

  5. Pharmaceutical Biotechnology

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. The identification of free cysteine residues within antibodies and a potential role for free cysteine residues in covalent aggregation because of agitation stress (pages 1701–1711)

      Joon H. Huh, April J. White, Stephen R. Brych, Heather Franey and Masazumi Matsumura

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23505

    2. Asparagine deamidation dependence on buffer type, pH, and temperature (pages 1712–1723)

      Amanda L. Pace, Rita L. Wong, Yonghua Taylor Zhang, Yung-Hsiang Kao and Y. John Wang

      Version of Record online: 8 APR 2013 | DOI: 10.1002/jps.23529

    3. The formation of oxytocin dimers is suppressed by the zinc–aspartate–oxytocin complex (pages 1734–1741)

      Christina Avanti, Wouter L.J. Hinrichs, Angela Casini, Anko C. Eissens, Annie Van Dam, Alexej Kedrov, Arnold J. M. Driessen, Henderik W. Frijlink and Hjalmar P. Permentier

      Version of Record online: 15 APR 2013 | DOI: 10.1002/jps.23546

  6. Pharmaceutics, Drug Delivery and Pharmaceutical Technology

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrug (pages 1742–1751)

      Jonathan Brown, Caly Chien, Peter Timmins, Andrew Dennis, Walter Doll, Erik Sandefer, Richard Page, Richard E. Nettles, Li Zhu and Dennis Grasela

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23476

    2. Identification of the degradation products of the steroid sulfatase inhibitor KW-2581 in jet mill-micronized powder (pages 1760–1772)

      Masashi Aoki, Hikaru Nishimura, Akihiro Mimura, Shoji Kita, Tohru Yasuzawa and Katsuhide Terada

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23513

    3. Accurate prediction of collapse temperature using optical coherence tomography-based freeze-drying microscopy (pages 1773–1785)

      Kristyn Greco, Mircea Mujat, Kristin L. Galbally-kinney, Daniel X. Hammer, R. Daniel Ferguson, Nicusor Iftimia, Phillip Mulhall, Puneet Sharma, William J. Kessler and Michael J. Pikal

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23516

    4. Critical factors in the measurement of tablet film coatings using terahertz pulsed imaging (pages 1813–1824)

      Daniela Brock, J. Axel Zeitler, Adrian Funke, Klaus Knop and Peter Kleinebudde

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23521

    5. Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles (pages 1825–1835)

      Khodadust Rouhollah, Mutlu Pelin, Yalcin Serap, Unsoy Gozde and Gunduz Ufuk

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23524

    6. New co-spray-dried tobramycin nanoparticles–clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients (pages 1836–1846)

      Gabrielle Pilcer, Rémi Rosière, Karl Traina, Thami Sebti, Francis Vanderbist and Karim Amighi

      Version of Record online: 8 APR 2013 | DOI: 10.1002/jps.23525

    7. Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet tablet containing a single excipient (pages 1859–1868)

      Christopher Mcconville, David R. Friend, Meredith R. Clark and Karl Malcolm

      Version of Record online: 8 APR 2013 | DOI: 10.1002/jps.23528

    8. Application of quality by design concepts in the development of fluidized bed granulation and tableting processes (pages 1869–1882)

      Jelena Djuris, Djordje Medarevic, Marko Krstic, Zorica Djuric and Svetlana Ibric

      Version of Record online: 8 APR 2013 | DOI: 10.1002/jps.23530

    9. Photostability of crystalline versus amorphous nifedipine and nimodipine (pages 1883–1894)

      Driekus Grooff, Farzaana Francis, Melgardt M. De Villiers and Ernst Ferg

      Version of Record online: 16 APR 2013 | DOI: 10.1002/jps.23533

    10. The use of near-infrared and microwave resonance sensing to monitor a continuous roller compaction process (pages 1895–1904)

      John Austin, Anshu Gupta, Ryan Mcdonnell, Gintaras V. Reklaitis and Michael T. Harris

      Version of Record online: 8 APR 2013 | DOI: 10.1002/jps.23536

    11. Impact of artificial plaque composition on drug transport (pages 1905–1914)

      Ji Guo, David M. Saylor, Ethan P. Glaser and Dinesh V. Patwardhan

      Version of Record online: 8 APR 2013 | DOI: 10.1002/jps.23537

    12. Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion (pages 1915–1923)

      Yuejun Song, Lianyan Wang, Ping Yang, Robert M. Wenslow Jr., Bo Tan, Hailu Zhang and Zongwu Deng

      Version of Record online: 11 APR 2013 | DOI: 10.1002/jps.23538

    13. Analysis of transcutaneous antigenic protein delivery by a hydrogel patch formulation (pages 1936–1947)

      Kazuhiko Matsuo, Yumiko Ishii, Yasuaki Kawai, Yuki Saiba, Ying-Shu Quan, Fumio Kamiyama, Sachiko Hirobe, Naoki Okada and Shinsaku Nakagawa

      Version of Record online: 12 APR 2013 | DOI: 10.1002/jps.23540

    14. Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion (pages 1948–1956)

      Nicole K. Brogden, Priyanka Ghosh, Lucia Hardi, Leslie J. Crofford and Audra L. Stinchcomb

      Version of Record online: 15 APR 2013 | DOI: 10.1002/jps.23544

    15. An augmented volume-based model of the glass transition temperature of 209 molecular liquids (pages 1970–1980)

      Ulrich P. Preiss and Muhammad I. Saleh

      Version of Record online: 17 APR 2013 | DOI: 10.1002/jps.23553

    16. Evaluation of cell-penetrating peptide/adenovirus particles for transduction of CAR-negative cells (pages 1981–1993)

      Adane S. Nigatu, Sravanthi Vupputuri, Nicholas Flynn, Brian J. Neely and Joshua D. Ramsey

      Version of Record online: 16 APR 2013 | DOI: 10.1002/jps.23556

  7. Pharmaceutical Nanotechnology

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. Docetaxel-loaded solid lipid nanoparticles: Preparation, characterization, in vitro, and in vivo evaluations (pages 1994–2004)

      Navid Mosallaei, Mahmoud Reza Jaafari, Mohammad Yahya Hanafi-Bojd, Shiva Golmohammadzadeh and Bizhan Malaekeh-Nikouei

      Version of Record online: 5 APR 2013 | DOI: 10.1002/jps.23522

  8. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Rapid Communication
    5. Rapid Communications
    6. Pharmaceutical Biotechnology
    7. Pharmaceutics, Drug Delivery and Pharmaceutical Technology
    8. Pharmaceutical Nanotechnology
    9. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism
    1. Pharmacokinetics and metabolism of SRX246: A potent and selective vasopressin 1a antagonist (pages 2033–2043)

      Karine M. Fabio, Christophe D. Guillon, Shi-fang Lu, Ned D. Heindel, Michael J. Brownstein, Carl J. Lacey, Carrie Garippa and Neal G. Simon

      Version of Record online: 7 MAR 2013 | DOI: 10.1002/jps.23495

    2. Time-dependent interaction of ritonavir in chronic use: The power balance between inhibition and induction of P-glycoprotein and cytochrome P450 3A (pages 2044–2055)

      Keizo Fukushima, Shinji Kobuchi, Kazunori Mizuhara, Hiroaki Aoyama, Kanji Takada and Nobuyuki Sugioka

      Version of Record online: 15 APR 2013 | DOI: 10.1002/jps.23545

    3. Pharmacokinetic/pharmacodynamic modeling of 5-fluorouracil by using a biomarker to predict tumor growth in a rat model of colorectal cancer (pages 2056–2067)

      Shinji Kobuchi, Yukako Ito, Kae Okada, Kazuki Imoto, Shota Kuwano and Kanji Takada

      Version of Record online: 16 APR 2013 | DOI: 10.1002/jps.23547

SEARCH

SEARCH BY CITATION